Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Biopharmaceutical Third-Party Logistics Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The biopharmaceutical third-party logistics market has experienced significant expansion in recent years. It is anticipated to grow from $150.5 billion in 2025 to $161.71 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. This historical growth can be attributed to the increase in biologics and vaccine production, the rising trend of pharmaceutical companies outsourcing logistics services, the broadening of global biopharmaceutical supply chains, more stringent regulatory requirements for drug transportation, and the limited internal logistics capabilities of biopharma firms.
The biopharmaceutical third-party logistics market is projected to experience robust expansion in the coming years. This market is forecast to reach $221.15 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.1%. Factors contributing to this growth over the forecast period include the escalating demand for personalized medicines, the broadening distribution of cell and gene therapies, increased investments in intelligent logistics platforms, a heightened emphasis on comprehensive supply chain visibility, and the expansion of international biopharmaceutical commerce. Key trends anticipated during this period involve a greater uptake of sophisticated cold chain logistics solutions, an elevated need for services for temperature-controlled transportation, the expanding utilization of platforms for real-time shipment tracking, the development of specialized warehousing facilities for biopharmaceuticals, and an intensified commitment to logistics operations that comply with regulations.
Get A Free Sample Report With In-Depth Market Insights:
Biopharmaceutical Third-Party Logistics Market Growth Drivers: What’s Behind The Acceleration?
The increasing adoption of outsourced logistics is anticipated to fuel the expansion of the biopharmaceutical third-party logistics market. This practice entails contracting a third-party entity to manage either all or specific segments of a firm’s logistics operations. Within biopharmaceutical third-party logistics, outsourcing logistics is specifically employed for entrusting cryogenic supply chain management to specialized logistics partners. As an illustration, data from February 2024, published by the Bureau of Transportation Statistics, a US-based division of the Department of Transportation (DOT), showed that for-hire freight shipments experienced a 1.8% increase in December 2023 relative to December 2022, concurrently, the Freight Transportation Services Index climbed from 136.6 in December 2022 to 139.1 in December 2023. Consequently, the increasing inclination towards outsourcing logistics is projected to accelerate the development of the biopharmaceutical third-party logistics market.
Biopharmaceutical Third-Party Logistics Market Segment Landscape: Which Areas Lead Development?
The biopharmaceutical third-party logistics market covered in this report is segmented –
1) By Supply Chain: Cold Chain, Non-Cold Chain
2) By Service: Transportation, Warehousing And Storage, Other Services
3) By End-User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Hospitals And Clinics, Other End-Users
Subsegments:
1) By Cold Chain: Refrigerated Transport, Temperature-Controlled Storage, Specialized Packaging
2) By Non-Cold Chain: Ambient Transport, Standard Storage Solutions, General Packaging Methods
Biopharmaceutical Third-Party Logistics Market Trends: What’s Defining The Industry’s Next Phase?
Key companies operating in the biopharmaceutical third-party logistics market are concentrating on developing innovative approaches, such as expanding their business in life sciences and healthcare logistics, to improve their capabilities for handling pharmaceutical and healthcare products, thus ensuring efficient storage and distribution. This expansion in life sciences and healthcare logistics represents the strategic advancement of logistics companies to bolster their capacity for transporting and managing medical items, which is critical for guaranteeing timely delivery and preserving the integrity of temperature-sensitive goods vital for patient care. As an illustration, in May 2025, DHL Group, a Germany-based logistics firm, announced the official opening of its upgraded Life Sciences & Healthcare (LSH) campus located in Florstadt, Germany. This new facility incorporates ultra-cold storage areas (down to –70°C), real-time tracking systems, and GDP-certified infrastructure, facilitating the secure management of temperature-sensitive biopharmaceuticals, including mRNA vaccines, materials for clinical trials, and advanced therapies.
Biopharmaceutical Third-Party Logistics Market Industry Leaders And Competitive Landscape
Major companies operating in the biopharmaceutical third-party logistics market are McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics
View The Full Biopharmaceutical Third-Party Logistics Market Report:
Biopharmaceutical Third-Party Logistics Market Geographic Spread And Regional Opportunities
North America was the largest region in the biopharmaceutical third party logistics market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical third-party logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model







